Table 2. Follow-up participation by screening methods and baseline results N (%).

	Within 3 years	Within 6 years	Within 10 years
All population*	2,394 (16.3%)	11,018 (74.9%)	12,936 (87.9%)
Primary cytology	1,611 (21.8%)	6,041 (81.6%)	6,655 (89.9%)
Primary HPV	783 (10.7%)	4,977 (68.1%)	6,281 (85.9%)
Cytology negative	1,493 (20.6%)	5,909 (81.4%)	6,519 (89.8%)
Cytology positive	118 (81.9%)	132 (91.7%)	136 (94.4%)
HPV negative	495 (7.2%)	4,595 (66.5%)	5,895 (85.3%)
HPV positive	288 (71.3%)	382 (94.6%)	386 (95.5%)

*All population: women participating at baseline; HPV, human papillomavirus.